Abbott Laboratories Stock News

Chemiluminescence Immunoassay Market The chemiluminescence immunoassay market was valued at USD 6000 million in 2019 and is expected to grow with a CAGR of 7.5% during the forecast period. Immunoassays are bio analytical procedures which are used in the diagnosis of various disease. The

Valley Brook Capital Group Inc. lowered its stake in shares of Abbott Laboratories (NYSE:ABT) by 2.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,487 shares of the healthcare product maker’s stock after selling 250 shares during the period. Abbott Laboratories accounts for 1.5% of […]

Founders Capital Management LLC lifted its holdings in Abbott Laboratories (NYSE:ABT) by 1.7% during the third quarter, HoldingsChannel reports. The firm owned 32,008 shares of the healthcare product makers stock after purchasing an additional 529 shares during the period. Abbott Laboratories comprises 1.0% of Founders Capital Management LLCs investment portfolio, making the stock its 24th []

DUBLIN--(BUSINESS WIRE)--The "Clinical Laboratory Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com''s offering. The global clinical laboratory services market exhibited moderate growth during 2015-2020. Looking forward, the publisher expects the market to grow at a CAGR of around 6% during 2021-2026. Companies Mentioned Abbott Laboratories Becton Dickinson Company bioMerieux SA Charles River Laborato

ProVise Management Group LLC reduced its stake in Abbott Laboratories (NYSE:ABT) by 6.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,436 shares of the healthcare product makers stock after selling 465 shares during the period. ProVise Management Group []

Assenagon Asset Management S.A. increased its stake in shares of Abbott Laboratories (NYSE:ABT) by 762.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,103 shares of the healthcare product makers stock after buying an additional 30,147 shares during the quarter. Assenagon []

Despite the COVID-19 pandemic induced challenges, rising demand for IVD coupled with dependence on AI & Robotics should lend support to the Zacks Medical-Products industry. ABT, BIO and HRC are well-p

Key Players Covered in the Point of Care Diagnostics Market Research Report Are F. Hoffmann-La Roche Ltd (Basel, Switzerland), Thermo Fisher Scientific Inc. (Massachusetts, U.S.), Abbott Laboratories (Illinois, U.S), Quest Diagnostics Incorporated (New Jersey, United States), BD (Franklin Lakes, U.S), bioMérieux SA (Marcy l''Etoile, France), Cardinal Health, Inc. (Ohio, U.S), Mesa Biotech (California, U.S), Cepheid (California, U.S), Trinity Biotech (Bray, Ireland), Quidel Corporation (San Diego, U.S.), Bio-Rad Laboratories Inc. (California, U.S) and other key market players Key Players Covered in the Point of Care Diagnostics Market Research Report Are F. Hoffmann-La Roche Ltd (Basel, Switzerland), Thermo Fisher Scientific Inc. (Massachusetts, U.S.), Abbott Laboratories (Illinois, U.S), Quest Diagnostics Incorporated (New Jersey, United States), BD (Franklin Lakes, U.S), bioMérieux SA (Marcy l''Etoile, France), Cardinal Health, Inc. (Ohio, U.S), Mesa Biotech (California, U.S), Cepheid (California, U.

6 Dividend Increases Expected In December 2021

Pune , India , 2021-Dec-07 /EPR Network/ The global In-vitro diagnostics market size is projected to reach USD 96.0 billion by 2025 from [read full press release]

Related Stocks: TXN , ABT , LMNX , FB , VGT ,

Kessler Investment Group LLC decreased its position in Abbott Laboratories (NYSE:ABT) by 1.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 19,990 shares of the healthcare product makers stock after selling 224 shares during the period. Abbott Laboratories makes up approximately []

The Latest survey report on Nutrition and Dietary Supplements Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Nutrition and Dietary Supplements organizations have the dual challenge of increasing interoperability []

Investors Financial Group LLC increased its position in Abbott Laboratories (NYSE:ABT) by 12.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,386 shares of the healthcare product makers stock after purchasing an additional 385 shares during the period. Investors []

The Global Portable Blood Gas and Electrolyte Analyzers Market report offers a comprehensive evaluation of the market. It does give in-depth analysis via qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have